-
1 Comment
RaySearch Laboratories AB (publ) is currently in a long term uptrend where the price is trading 4.8% above its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.2.
RaySearch Laboratories AB (publ)'s total revenue sank by 49.2% to $119M since the same quarter in the previous year.
Its net income has dropped by 238.3% to $-26M since the same quarter in the previous year.
Finally, its free cash flow fell by 50.1% to $41M since the same quarter in the previous year.
Based on the above factors, RaySearch Laboratories AB (publ) gets an overall score of 2/5.
ISIN | SE0000135485 |
---|---|
Sector | Healthcare |
Industry | Health Information Services |
Exchange | F |
CurrencyCode | EUR |
Dividend Yield | 1.0% |
---|---|
PE Ratio | 44.07 |
Target Price | None |
Beta | 1.09 |
Market Cap | 820M |
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. The company offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation* (Micro-RayStation), a software platform for planning and evaluation in small animal irradiation research; RayPlan, a treatment planning system; DrugLog, which verifies the identity and concentration of compounded injectables before administered to a patient; RayMigrate, allows users to convert Pinnacle patient data to RayStation format and/or to DICOM format; and machine learning and liver ablation solutions. It has collaboration with Vision RT for integration of MapRT with RayStation treatment planning system. The company was founded in 2000 and is headquartered in Stockholm, Sweden.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 27R.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025